首页> 外文期刊>FEBS Open Bio >Panax notoginseng saponins alleviate skeletal muscle insulin resistance by regulating the IRS1–PI3K–AKT signaling pathway and GLUT4 expression
【24h】

Panax notoginseng saponins alleviate skeletal muscle insulin resistance by regulating the IRS1–PI3K–AKT signaling pathway and GLUT4 expression

机译:三七总皂苷通过调节IRS1-PI3K-AKT信号通路和GLUT4表达减轻骨骼肌胰岛素抵抗

获取原文
获取外文期刊封面目录资料

摘要

Panax notoginseng saponins (PNS) are a commonly used traditional medicine to treat diabetes in China. Recent studies have confirmed their anti‐diabetic effects, but the underlying mechanisms have remained unclear. The present study was designed to explore whether PNS decrease hyperglycemia by improving insulin sensitivity in skeletal muscle and to elucidate the molecular mechanisms. The anti‐diabetic effects of PNS were analyzed in a skeletal myoblast cell line, C2C12, and in high fat diet‐induced diabetic KKAy mice. C2C12 cells were treated with PNS (50, 100, and 200?μg·Lsup?1/sup) and examined for glucose uptake, cell viability and expression of components of the phosphoinositide 3‐kinase (PI3K)–protein kinase B (AKT) signaling pathway. KKAy mice were intraperitoneally injected with PNS (200?mg·kgsup?1/sup) for 6?weeks. Body weight, blood glucose, serum insulin, serum lipid, glucose and insulin tolerance were measured to evaluate the anti‐diabetic effects of PNS. Pathological changes, apoptosis and the PI3K–AKT signaling pathway were analyzed in KKAy skeletal muscle. PNS significantly increased insulin‐induced glucose uptake, but did not affect the cell viability of C2C12 cells. In addition, PNS reduced blood glucose and serum insulin levels and improved glucose tolerance and insulin tolerance of KKAy mice. Pathological changes and apoptosis of skeletal muscle were relieved by PNS treatment. Moreover, PNS treatment enhanced expression of mRNA encoding IRS1 and GLUT4, as well as the protein expression of phosphorylated (p) ‐insulin receptor substrate 1 (IRS1), p‐PI3K, p‐AKT and glucose transporter type 4 (GLUT4) in C2C12 and KKAy mouse muscle. Collectively, these data indicate that PNS reduces hyperglycemia and insulin resistance through up‐regulating GLUT4 expression and the IRS1–PI3K–AKT signaling pathway. Furthermore, PNS alleviated diabetes skeletal muscle pathological damage. Thus, our data suggest that PNS may be promising anti‐diabetic compounds.
机译:三七总皂甙(PNS)是中国治疗糖尿病的常用传统药物。最近的研究证实了它们的抗糖尿病作用,但其潜在机制仍不清楚。本研究旨在探讨PNS是否通过改善骨骼肌的胰岛素敏感性来降低高血糖症,并阐明其分子机制。在骨骼肌成肌细胞系C2C12和高脂饮食诱导的糖尿病KKAy小鼠中分析了PNS的抗糖尿病作用。用PNS(50、100和200?g·L ?1 )处理C2C12细胞,检查其葡萄糖摄取,细胞活力和磷酸肌醇3-激酶(PI3K)-蛋白的表达激酶B(AKT)信号通路。 KKAy小鼠腹膜内注射PNS(200?mg·kg ?1 )6周。测量体重,血糖,血清胰岛素,血脂,葡萄糖和胰岛素耐受性,以评估PNS的抗糖尿病作用。分析了KKAy骨骼肌的病理变化,凋亡和PI3K–AKT信号通路。 PNS显着增加胰岛素诱导的葡萄糖摄取,但不影响C2C12细胞的细胞生存能力。此外,PNS降低了血糖和血清胰岛素水平,并改善了KKAy小鼠的葡萄糖耐量和胰岛素耐量。 PNS治疗可减轻骨骼肌的病理变化和细胞凋亡。此外,PNS治疗增强了C2C12中编码IRS1和GLUT4的mRNA的表达以及磷酸化(p)胰岛素受体底物1(IRS1),p-PI3K,p-AKT和4型葡萄糖转运蛋白(GLUT4)的蛋白表达。和KKAy老鼠的肌肉。总体而言,这些数据表明PNS通过上调GLUT4表达和IRS1-PI3K-AKT信号通路降低高血糖和胰岛素抵抗。此外,PNS减轻了糖尿病骨骼肌的病理损伤。因此,我们的数据表明PNS可能是有前途的抗糖尿病化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号